NO964015D0 - Fremgangsmåte for påvisning av kalpain-aktivering og identifisering av kalpain-inhibitorer - Google Patents

Fremgangsmåte for påvisning av kalpain-aktivering og identifisering av kalpain-inhibitorer

Info

Publication number
NO964015D0
NO964015D0 NO964015A NO964015A NO964015D0 NO 964015 D0 NO964015 D0 NO 964015D0 NO 964015 A NO964015 A NO 964015A NO 964015 A NO964015 A NO 964015A NO 964015 D0 NO964015 D0 NO 964015D0
Authority
NO
Norway
Prior art keywords
calpain
identifying
detecting
activation
inhibitors
Prior art date
Application number
NO964015A
Other languages
English (en)
Other versions
NO964015L (no
Inventor
Robert Siman
Donna Bozyzko-Coyne
Original Assignee
Cephalon Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cephalon Inc filed Critical Cephalon Inc
Publication of NO964015L publication Critical patent/NO964015L/no
Publication of NO964015D0 publication Critical patent/NO964015D0/no

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/564—Immunoassay; Biospecific binding assay; Materials therefor for pre-existing immune complex or autoimmune disease, i.e. systemic lupus erythematosus, rheumatoid arthritis, multiple sclerosis, rheumatoid factors or complement components C1-C9
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4711—Alzheimer's disease; Amyloid plaque core protein
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/81—Protease inhibitors
    • C07K14/8107—Endopeptidase (E.C. 3.4.21-99) inhibitors
    • C07K14/8139—Cysteine protease (E.C. 3.4.22) inhibitors, e.g. cystatin
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/573—Immunoassay; Biospecific binding assay; Materials therefor for enzymes or isoenzymes
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • G01N33/6896—Neurological disorders, e.g. Alzheimer's disease

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Food Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Biotechnology (AREA)
  • Cell Biology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Microbiology (AREA)
  • General Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Neurology (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Neurosurgery (AREA)
  • Rehabilitation Therapy (AREA)
  • Rheumatology (AREA)
  • Peptides Or Proteins (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
NO964015A 1994-03-25 1996-09-24 Fremgangsmåte for påvisning av kalpain-aktivering og identifisering av kalpain-inhibitorer NO964015D0 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/217,989 US5536639A (en) 1994-03-25 1994-03-25 Methods for detecting calpain activation by detection of calpain activated spectrin breakdown products
PCT/US1995/002279 WO1995026506A1 (en) 1994-03-25 1995-02-21 Methods for detecting calpain activation and indentifying calpain inhibitors

Publications (2)

Publication Number Publication Date
NO964015L NO964015L (no) 1996-09-24
NO964015D0 true NO964015D0 (no) 1996-09-24

Family

ID=22813313

Family Applications (1)

Application Number Title Priority Date Filing Date
NO964015A NO964015D0 (no) 1994-03-25 1996-09-24 Fremgangsmåte for påvisning av kalpain-aktivering og identifisering av kalpain-inhibitorer

Country Status (8)

Country Link
US (2) US5536639A (no)
EP (1) EP0752103A1 (no)
JP (1) JPH09511332A (no)
AU (1) AU1929695A (no)
CA (1) CA2185141A1 (no)
FI (1) FI963811A (no)
NO (1) NO964015D0 (no)
WO (1) WO1995026506A1 (no)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69637307T2 (de) * 1995-11-28 2008-02-28 Cephalon, Inc. Aus d-aminosäuren abgeleitete cystein-und serinproteasehemmer
EP0799892A3 (en) * 1996-04-05 1998-08-12 Takeda Chemical Industries, Ltd. Calpain, its production and use
US6303579B1 (en) 1996-10-31 2001-10-16 Alcon Laboratories, Inc. Use of calpain inhibitors to treat ocular neural pathology
US6048703A (en) * 1996-11-15 2000-04-11 Cephalon, Inc. Methods for detecting cell apoptosis
GB9704312D0 (en) * 1997-03-01 1997-04-23 Univ Nottingham Diagnostic assay
DE69937835T2 (de) * 1998-09-24 2009-01-02 Promega Corp., Madison Antikörper für apoptosemarker und anwendungsverfahren
EP1172443A4 (en) * 1999-03-19 2004-11-17 Yamanouchi Pharma Co Ltd METHOD FOR SCREENING AN INHIBITOR OF THE CYSTEIN PROTEASE
AUPQ656500A0 (en) * 2000-03-28 2000-04-20 Autogen Pty Ltd A method of treatment and agents for same
EP1285092A4 (en) * 2000-04-14 2003-07-16 Metabolon Inc METHOD FOR DISCOVERY OF MEDICINES, DISEASE TREATMENT AND DIAGNOSIS USE THE METABOLOMICS
US7329489B2 (en) * 2000-04-14 2008-02-12 Matabolon, Inc. Methods for drug discovery, disease treatment, and diagnosis using metabolomics
EP2348317B1 (en) * 2002-09-11 2014-12-03 University Of Florida Research Foundation, Inc. Detection of traumatic brain injury using alpha II spectrin break-down products (SBDP)
US8492107B2 (en) 2004-04-15 2013-07-23 University Of Florida Research Foundation, Inc. Neural proteins as biomarkers for nervous system injury and other neural disorders
ES2367311T3 (es) 2004-04-15 2011-11-02 University Of Florida Research Foundation, Inc. Productos de degradación proteolítica de map-2 como biomarcadores de diagnóstico para las lesiones neurales.
ES2482142T3 (es) 2004-04-15 2014-08-01 University Of Florida Research Foundation, Inc. Proteínas neurales como biomarcadores para lesiones del sistema nervioso y otros trastornos neurales
WO2008033575A2 (en) * 2006-09-15 2008-03-20 Metabolon, Inc. Methods of identifying biochemical pathways
WO2008097618A1 (en) * 2007-02-06 2008-08-14 University Of Florida Research Foundation, Inc. Synaptotagmin and collapsin response mediator protein as biomarkers for traumatic brain injury
NO2324360T3 (no) 2008-08-11 2018-06-30

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5118606A (en) * 1988-09-02 1992-06-02 The Regents Of The University Of California Methods for detecting cellular pathology by assaying spectrin and spectrin breakdown products
JPH06504061A (ja) * 1990-12-28 1994-05-12 コーテックス　ファーマシューティカルズ　インコーポレイテッド 神経変性の治療および予防におけるカルパイン阻害剤の使用
US5444042A (en) * 1990-12-28 1995-08-22 Cortex Pharmaceuticals Method of treatment of neurodegeneration with calpain inhibitors

Also Published As

Publication number Publication date
FI963811A0 (fi) 1996-09-24
NO964015L (no) 1996-09-24
WO1995026506A1 (en) 1995-10-05
AU1929695A (en) 1995-10-17
US5871712A (en) 1999-02-16
CA2185141A1 (en) 1995-10-05
JPH09511332A (ja) 1997-11-11
FI963811A (fi) 1996-09-24
US5536639A (en) 1996-07-16
EP0752103A1 (en) 1997-01-08

Similar Documents

Publication Publication Date Title
NO970762L (no) Brönnstrengskjötlokalisator og fremgangsmåte derved
DE69724397D1 (de) Informationsverarbeitungsgerät und -verfahren
DE69632555D1 (de) Aufzeichnungsgerät und -verfahren
NO952283D0 (no) Framgangsmåte og anordning for montasje av tetning
NO974547L (no) Framgangsmåte og anordning for detektering og framvising av momentviberasjon
DE69712725D1 (de) Informationsverarbeitungsgerät und -verfahren
NO964015D0 (no) Fremgangsmåte for påvisning av kalpain-aktivering og identifisering av kalpain-inhibitorer
DE69739432D1 (de) Informationsverarbeitungsgerät und -verfahren
DE69625891T2 (de) Verfahren und Gerät zum Identifizieren von Fingerabdrücken
DE19681292T1 (de) Gravierfehlerdetektionsvorrichtung und -verfahren
NO972578L (no) FremgangsmÕte og anordning for forsegling
DE69520753D1 (de) Plattenkassettenerfassungsverfahren und -vorrichtung
DE69838897D1 (de) Aufzeichnungsverfahren und -vorrichtung
NO974060L (no) Anordning og fremgangsmÕte for regenerering av t°rkemiddel
NO992509D0 (no) Anordning og fremgangsmÕte for bruk av dielektrokinese for Õ lokalisere objekter
DE69704880D1 (de) Fehlererkennungsgerät und verfahren
NO963943L (no) Fremgangsmåte og utstyr for detektering av fluider
DE69620692D1 (de) Aufzeichnungsgerät und -verfahren
DE69713638T2 (de) Informationsverarbeitungsgerät und -methode
DE69803598T2 (de) Nachweisverfahren und -vorrichtung
DE69501618D1 (de) Einrichtung und verfahren zum erkennen von fälschungen
DE69723774D1 (de) Verfahren und Vorrichtung zum Empfang von Informationen
NO20004686D0 (no) Anordning for og fremgangsmÕte ved identifisering av gjenstander
ITMI940146A1 (it) Apparecchiatura e metodo per rilevare perforazioni
NO994152L (no) Fremgangsmate og innretning for bestemmelse av avstander

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application